Versor Investments LP Makes New Investment in Cognex Corporation $CGNX

Versor Investments LP bought a new position in Cognex Corporation (NASDAQ:CGNX) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 41,609 shares of the scientific and technical instruments company’s stock, valued at approximately $1,320,000.

Several other hedge funds also recently bought and sold shares of CGNX. Nordea Investment Management AB raised its holdings in Cognex by 148.5% in the second quarter. Nordea Investment Management AB now owns 7,075,772 shares of the scientific and technical instruments company’s stock worth $223,594,000 after purchasing an additional 4,228,729 shares during the period. Mackenzie Financial Corp raised its holdings in Cognex by 126.2% in the first quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company’s stock worth $137,510,000 after purchasing an additional 2,571,457 shares during the period. T. Rowe Price Investment Management Inc. raised its holdings in Cognex by 32.0% in the first quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company’s stock worth $181,436,000 after purchasing an additional 1,474,832 shares during the period. ING Groep NV acquired a new stake in Cognex in the first quarter worth $22,191,000. Finally, Price T Rowe Associates Inc. MD raised its holdings in Cognex by 34.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,539,557 shares of the scientific and technical instruments company’s stock worth $75,756,000 after purchasing an additional 647,955 shares during the period. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Robert Willett sold 6,704 shares of the firm’s stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total value of $331,915.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Sheila Marie Dipalma sold 2,002 shares of the firm’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $45.00, for a total transaction of $90,090.00. Following the completion of the transaction, the executive vice president directly owned 8,582 shares of the company’s stock, valued at approximately $386,190. This trade represents a 18.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 10,706 shares of company stock valued at $512,065. 1.60% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CGNX. The Goldman Sachs Group increased their target price on shares of Cognex from $36.00 to $40.00 and gave the stock a “sell” rating in a report on Tuesday, September 16th. Weiss Ratings reissued a “hold (c)” rating on shares of Cognex in a research report on Wednesday, October 8th. Truist Financial set a $45.00 price objective on shares of Cognex and gave the stock a “hold” rating in a research report on Wednesday, October 8th. KeyCorp reissued an “overweight” rating and set a $50.00 price objective on shares of Cognex in a research report on Friday. Finally, Needham & Company LLC increased their price objective on shares of Cognex from $45.00 to $47.00 and gave the stock a “buy” rating in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $46.00.

Cognex Trading Up 0.2%

Cognex stock opened at $41.39 on Friday. The company has a market cap of $6.95 billion, a P/E ratio of 64.67 and a beta of 1.50. Cognex Corporation has a 1-year low of $22.67 and a 1-year high of $49.76. The company has a fifty day simple moving average of $45.30 and a 200 day simple moving average of $37.06.

Cognex (NASDAQ:CGNX) last released its earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. The business had revenue of $276.89 million during the quarter, compared to the consensus estimate of $261.86 million. Cognex had a net margin of 11.33% and a return on equity of 8.26%. The firm’s revenue for the quarter was up 18.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.20 earnings per share. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. On average, equities research analysts forecast that Cognex Corporation will post 0.61 EPS for the current year.

Cognex Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 28th. Investors of record on Thursday, November 13th will be given a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a yield of 0.8%. This is an increase from Cognex’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend is Thursday, November 13th. Cognex’s payout ratio is 50.00%.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.